24-hour brachial systolic pressure
30-day death/all-cause readmission
72-hour cumulative urine volume
abnormal cardiac
abnormal liver texture
abnormal scn5a mrna splicing
abrogate pathological gene expression
acetylcholinesterase inhibitor pyridostigmine
acquired heart
acs procedures
actin cytoskeleton pathways
action
activation
activators
active
active treatment
acute anthracycline-induced cardiotoxicity
acute autonomic nervous system modulation
acute care hospital
acute care hospitals
acute decompensated hf
acute heart failure clinical trials
acute hf trials
acute pulmonary embolism
acute treatment of heart failure
acute β-ar stimulation
ad-c
ad-flk
ad-flk rats
adaptive
adenoviral vector
adherence
adjunctive treatment
adjuvant setting
administration
administration of contrast agent
administrative databases
administrative health
admission median bnp
admission to discharge
adrenergic receptor
adrenergic receptor blockade
adult male wistar rats
advanced copd
advanced heart failure
advanced heart failure therapy
adverse cardiovascular
adverse cv
adverse event rates
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
af patients
af type
af-free probability
age
age-
aggressive protocols
aging
agonist
air pollution
akt
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
all-cause
allopurinol rats
alphalisa immunoassays
altered protein kinase
alternative
am
ambulatory heart failure trial
ambulatory hf patients
ambulatory icd patients
ambulatory patients
american heart association guidelines
ami mortality rates
ami patient
amino-terminal
amyloidotic pattern
an
anemia in adults
anemia treatment
ang ii infusion mouse
angeli
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor antagonist valsartan
angiotensin receptor blockers therapy
angle
angle descending arter
angle-to-edge anastomosis
animals
ann arbor veterans affairs hf clinic
annular plane systolic excursion
annular size reduction
annulus velocity
ans
anterior leaflet opening
anthracycline exposure
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer
anti- inflammatory effects
antiarrhythmic medication
antitumor activity
aortic blood flow
aortic pressure curve
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical
apical rotation
appendicular lean mass index
aric hf
aric hf model
arrhythmia substrate
arrhythmia-related costs
arterial compliance
artificial pulse
as
associations
atheromatous coronary disease
atherosclerosis risk
atp demand
atp production rates
atrial explant-derived c-kit
atrial fibrillation/flutter
atrial structure
autonomic nervous system activity
b
b act via activation
b-treated
barriers
barriers to exercise
basal
basal contractility
basal rotations
baseline crf
baseline ecgs
baseline echocardiography
baseline electrocardiogram
baseline glomerular filtration rate
baseline hrqol
baseline nt-probnp
baseline serum creatinine
baseline sst2 status
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt
beat-to-beat qt interval
behavioural-change
benefits
bet bromodomain-containing protein
bet family bromodomain proteins
bet inhibition suppresses a pathological cardiac gene expression programme
beta-blocker dose
beta-blocker hypo-response
beta-blocker therapy
bhlh transcription factor hand2
binding
bioinformatic analysis
biological
biomarker in heart failure
biomarker-guided clinical
biomarker-guided clinical trial
biomedical reasons
biomedical treatment
black ethnicity
black patients
black race
black race in patients
blacks
blinded core laboratory
blocker-induced enhancement
blood pressure control
blood testing
blunted cardiac β-ar responsiveness
blunts beta-adrenergic responses
body
body composition
body fat distribution
body mass
body weight
bone morphogenetic protein
bradycardia induced
branch block electrical activation
breakdown
breast cancer patients
breath-holding
breathing control
bridge to recovery
bridging therapy
bt
burden
c-kit
c-terminally processed forms
c-terminally truncated fragments
c57bl
ca(2+)-pump
ca(2+)-uptake
ca2
calf muscle
california office of statewide health planning
caloric restriction
camp hydrolytic activity
camp production
camp-dependent protein kinase
canadian cardiovascular society guidelines
cancer
cancers
candesartan in heart failure assessment
canine model
cardiac autonomic balance
cardiac benign tumors
cardiac c-kit
cardiac centre
cardiac development
cardiac diameters
cardiac explant c-kit
cardiac explant-derived cells
cardiac genes
cardiac hypertrophic response
cardiac hypertrophy secondary to pressure-overload
cardiac insulin-resistance
cardiac irs1
cardiac magnetic resonance postcontrast
cardiac mena deletion
cardiac myocyte-specific mena
cardiac na+ current
cardiac nurse
cardiac nurses
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac procedures
cardiac rehabilitation care
cardiac resynchronization
cardiac sodium current
cardiac specialty hospital
cardiac surgery
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac tissue
cardiac transplant survival
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology services
cardiology-cardiovascular surgery
cardiomyocyte-like cells in vitro
cardiomyopathic restriction
cardioprotective effect
cardiopulmonary exercise
cardiopulmonary exercise variables
cardiovascular complications
cardiovascular conditions
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular risk
cardiovascular risk factors
care management
care management coupled
carotid baroreflex activation therapy
carotid bodies
carotid intima-media
case-control study
caspase 3 expression
caspase-3 activity
catabolic/anabolic imbalance
catabolism
catalytic
catecholamine infusions
catheter-based percutaneous revascularization
caucasian
cause
cd
cd hf
cd133
cd34
cdp choline
cell differentiation
cell expansion
cell yield
centers for medicare
central glycosylated
centrimag right ventricular assist device
centrimag rvad
cf devices
cf lvad patients
change
charm programme
chelation choices
chelation regimens
chemical instability
chemotherapy-induced heart failure
chf atrial explants
chf patients
chf patients intubated
chf predictive model
chf visit
chf-dnx
chf-inv
chf-inv rabbits
childhood malignant disease
children
chinese herbal medicine
chm
chrmatin-associated proteins
chromatin remodeling
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic advanced heart failure patients
chronic disease
chronic heart failure chronic heart failure
chronic hf-ref
chronic hff
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology collaboration equation
chronic stable guideline-directed medical therapy
chronic β-adrenergic receptor stimulation
circulating cd34
circulating forms
circulating fragments
circulating mediator of insulin resistance
circulating nt-probnp
circulating plasma
circulatory arrest
circulatory derangement
circumferential shortening
class i recommendations
class ii
class ii heart failure
class iii
clcnka gg
clcnka polymorphism
clcnka snp
clin
clinical benefit
clinical change
clinical composite response
clinical diastolic dysfunction
clinical doppler echocardiography
clinical effects
clinical excellence
clinical follow-up of heart failure
clinical modification codes
clinical outcome
clinical prediction rule
clinical studies
clinical trial
clinical trial registries
clinical trials
clinical variables
co correlated
co-activating transcription factor networks
cochrane databases
cochrane effective practice
cogeneration
cognitive function
cognitive impairment
cohort
collagen density
college of cardiology
colon
comanagement
commissioning
communauté outpatient settings
competitive
complicating ami
computed tomographic angiography
computing readmissions
concurrent hf
conditional gene-targeted hand2 mice
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congestive heart
congestive heart failure patients
congestive heart failure trial
conjunction
conscious dogs
conscious rabbits
contemporary heart failure
content-driven telehealth system
content-driven telehealth technologie
continuous nris
contrast agent
control adenovirus
control group
controlled randomized trials
controlled trial investigating outcomes
controlled trial investigating outcomes of exercise training
correction
coupling
cox proportional hazard
cox proportional hazards
cox proportional hazards regression
coût
coût-effective
coût-effectiveness
cpet guiding exercise rehabilitation
cpg-recommended pharmacological treatment
creatine kinase activity
crf distribution
cronbach
cross-sec
crt implantation
crt off
crt on
crude rr
ct group
ctt
cultured cardiomyocytes
cumulative urine volume
cv death
cv events
cxl
cxl-1020 converts
cxl-1020)
cytotoxic effect
danish heart failure database
dash diet scores
deactivation
death/hospitalization/ed
debilitating chronic disease
debilitating stroke
decline
decongestion
decongestion end point
decoy vegf receptor
defibrillator-only therapy
deficits
degradation
delayed rhythm control
deleterious β1ar overstimulation
depressed left ventricular
depression
depressive symptoms
descriptive research
detergent
development patient discharge
device
device consideration
device therapies
devices
devices in heart failure
diabetic zsf1 rats
dialysis patients
dialysis-dependent patients
diameter stenosis
diastolic indices
diastolic properties
diet
diet group
dietary approaches
dietary sodium restriction
diffuse myocardial changes
direct
direct interaction
direct renin inhibitors
disappearance
discrimination
discrimination improvement
disease management
disease management programs in heart failure
disease progression
disease recapitulates
disease-specific costs
diseased human
disposition of at-risk patients
distance covered
distance walked
disturbed intestinal barrier
dithiothreitol
diuretic efficacy
diuretic peptides
diuretic refractory severe-end-stage hf
diuretic resistant volume overload in heart failure
diuretic response
diuretic therapy
dl
doppler early diastolic mitral
double mutant
doxorubicin cardiotoxicity
doxorubicin efflux transporter abcc2
doxorubicin-induced heart failure
dp-4 inhibitors
driveline infection
driveline injury
drs-stratified hazard ratios
drug abrogated
drug discontinuation
drug dose
drug-untreated failing hearts
dynamic
dynamique
early medical management
early transmitral flow
ec coupling gain
ecct patients
ecg parameters
echo-doppler studies
echocardiographic assessment
echocardiographic evaluations
echocardiographic evidence
echocardiographic examination
echocardiographic measurements
echocardiographic measures
echocardiographic predictors
echocardiographic score
echocardiographic substudy
echocardiographic systolic parameters
ecmo group
ecmo+vad
ecmo+vad group
economic evaluations
ed physicians
ed visits
eemean
effectiveness
efficiency
egfr group
ehesus
elastic n2bus segment
elderly
elderly patients
electric remodeling
electrical activation
electrical stimulation
electrocardiographic device
electromechanical behavior
embryonic gene programs
embryonic gene programs in heart failure
embryonic kidney
emd prolongation
emergency cardiac catheterization
emergency room practice
emotional status
emotional stress
empirically derived composite quality measure
end point of death
end-diastolic dimension
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energy deficit
energy expenditure
enos-ser
enos-thr
enrollment
epidemiologie
epigenetic changes
epigenetic readers in cardiac biology
eplerenone in mild patients hospitalization
eplerenone post myocardial infarction heart failure efficacy
er kinase
erasers
erythropoiesis-stimulating agent therapy
eseptal
et
ethically complex situations
etidronate-
european society of cardiology guidelines
evidence-based care in heart disease
evidence-based treatments
exercise
exercise adherence
exercise intolerance in heart failure
exercise performance
exercise training
exercise training in hf
expenditure
explant-derived progenitor cells
extracorporeal
extracorporeal membrane oxygenation membrane support
failing fontan
failing heart
failing hearts
families
family
fat
fat loss
fat-free
feasibility
fetal gene program
ff
fiber
figure
figure ejection fraction
figure-fatality rate
financiers
fish lacking
fit
fixed ring size
fixed-rate atrial pacing
flow-mediated dilatation diameter
fluo-camp binding
fluorescence resonance energy transfer-based assays
follow-up exercise capacity
food and drug administration
force generated
fraction
fractional
frailty in heart failure
france
free-breathing pulse sequence
fréquence
functional abnormalities
functional class nyha ii-iii
functional decline
functional deficits
functional enrichment
furosemide dose
futility
g-protein-coupled receptor kinase-2
gain
gating movement
gdmt-treated nyha functional class iii hf
gem
genes coding
geometry
global longitudinal strain
global proteomics changes
glomerular filtration
glucose transporter
glycolysis/gluconeogenesis
go test
gr index
grading of recommendations
grestar-kyoto
grls
gross income
gross national income per capita
groupes validity
grs
gtpase rac1 activity
guideline recommendations in heart failure
guideline-heart failure registry
guideline-recommended drugs
guideline-recommended medications
guideline-recommended treatment
guidelines-heart failure
h
h-dko mice
h-dnx
h-oxidase subunit rac2
h-ref
habc battery score
habc battery scores
haemodynamic outcomes
haemodynamic stress
hand
hand grip strength
hand2 in heart failure
handling
hard ratio
hct chf
hct germline dna
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-induced
hdl-induced no production
hdl-mediated protective effects
hdl-mediated vascular effects
health behaviors
health care expenditures
health insurance
health outcomes
health per capita
health service
health status
health system
healthcare common procedure codes
healthcare programmes
healthcare utilization effects
healthy cardiomyocytes
healthy control
heart association
heart failure adherence
heart failure admission
heart failure clinic
heart failure discharges
heart failure disease management
heart failure guidelines
heart failure hospitalization
heart failure mice
heart failure mortality
heart failure myocardial tissue
heart failure nurse
heart failure nurses
heart failure patients
heart failure rats
heart failure risk
heart failure-related hospitalization
heart failure-related mortality
heart muscle cells
heart pathologie
heart team
heart transplant recipients
heart-specific irs1
heartmate ii devices
heartmate ii lvad
heartware intl
heartware patients
helix-loop-helix
hemodynamic alterations
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically unstable
hemoglobin levels
hepatic function
hf admissions
hf canine electromechanics
hf clinic outpatients
hf complicating ami
hf epidemiologie
hf epidemiology
hf hospital admissions
hf hospitalization
hf induced
hf mortality
hf mortality risk
hf pathogenesis
hf pathophysiology
hf patient plasma
hf progression
hf rats
hf remodeling aspects
hf resources
hf risk
hf units
hf volume management
hf- inv
hf-action cohort
hf-dnx
hf-induced remodeling
hf-related cachexia
hfef
hff
hff therapy
hfpef patients
hfrf
hfvt
hg
hhf
high-fat diet
high-volume physicians
hnm
hnorm
hnorm group
hospital anxiety and depression
hospital days
hospital discharge
hospital discharge in patients
hospital mortality
hospital performance
hospital quality improvement initiative
hospital quality of care outcomes
hospital rankings
hospital readmission reduction
hospital stay
hospital volume
hospital-based programmes
hospitalization for heart failure
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hpef
hr dynamics
hr modulates ea
hr variability/turbulence
href
hretn
ht chest radiation
hum- retn mice
hum-retn mice
human failing hearts
human heart failure
human hf
human monocytes
human rad q66p
human resistin
human retn gene
humanized male mice
humanized mouse
humoral stimuli
hvad devices
hypertension diet
hypertensive heart
hz
i-meta-iodobenzylguanidine
i-mibg
i-mibg cardiac washout
icd-hf
icu mortality
if inhibitor ivabradine trial
il
immunoreactive nt-probnp
impaired cardiac energy metabolism
impaired right ventricular pump
implant aged
implant-hf
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implantable implantable cardioverter-defibrillator deactivation
implantable implantable cardioverter-defibrillator shocks
implantable implantable cardioverter-defibrillator therapy
implantable testosterone supplementation
implantal pro-brain natriuretic peptide
implantance
implantation eligibility status
implantation instability
implante
implanted cardioverter-defibrillator device
implanted heartmate
implanted left-right interatrial shunt
implanted monitoring devices
implanted new zealand white rabbits
implanted pluripotent stem cell-derived cardiomyocytes
implantg techniques
implanting
implanting in heart failure
implantions
implantive
implantologie
implantration
in vivo inhibition
in vivo rv length-force
in-trial resource utilization
inactive cxl-1051
inappropriate atp
inappropriate icd shocks
inappropriate therapy
incident cardiovascular events
incident hf
incident systolic heart failure
incubation
index
index admission
index ami
index beat
index ed visit
index hf
indices
inducible myocardial ischemia
industrial areas
inesthetized dogs
infarcted animals
infarcted hearts
infarcted left ventricle
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin
inflammatory abdominal
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
influx
ingenuity pathway
inhibit cardiac l-type channel activity
inhibition
inhibition halts heart failure
inhibitor jq1
inhibitory actions
inhospital mortality
inhospital outcomes
inimpaired lv relaxation
inoperable chronic thromboembolic pulmonary hypertension
inotrope-dependent
inpatient medical conditions
inpatient records
insertion
institution of pd
insulin action
insulin receptor substrates
insulin-signaling components
insulin-stimulated rates
insurance status
intact hearts
interagency registry
interclass correlation coefficient
interleukin receptor family
intermediate frail
intermediate metabolism
intermuscular fat ratio
internal consistency
international right heart foundation
interquartile
intervention
interventions
interventricular septum biopsies
intolerance
intracellular antiadrenergic therapeutic strategy
intravenous atropine
intravenous inotropes
intravenous iron
intravenous metoprolol
intubation rates
invasive hemodynamic
ip
iron
iron deficiency
iron-deficient adult patients
irs2 double-knockout
irs2 proteins
ischemic conditioning
ischemic etiology
ischemic hf pathogenesis
isoprenaline infusion
iv heart failure
ivabradine 5 mg
ivabradine group
ivabradine unloads
ivabradine-
ivabradine-tre
japanese heart failure
jehovah
joint effect
kaiser permanente northern california
kansas city cardiomyopathy
kaplan-meier
kcal
kccq domains
kccq scales
kg
kidney index score
kidney injury
kir
kv
kv4.3 channel mrnas
l-dko mice
l-type ca2
l-type channel inhibition
l-type channel isoforms
l-type voltage-gated ca
label-free shotgun proteomics
laboratory report
lancet
lateral wall
lcx model
leaflet motion
leaflet repair
lean zsf
lean zsf1 group
left
left main
left ventricular biopsies
left ventricular ejection
left ventricular mechanics
left ventricular tissue
left-hand grip strength
leg strength
length-force relationship
leu
lf
liberal transfusion protocols
life score
life-sustaining treatment
lifesaving drugs
lipid-lowering therapy
lipoprotein functional properties
lipoprotein-associated phospholipase
literature
littermate controls
liver-specific irs1
logistic regression models
lokomat® system
lokomat® system in heart failure
long-acting insulin
long-standing persistent af
long-term
long-term clinical outcomes
long-term mortality
long-term outcomes
long-term survival
long-term ventricular assist device
longitudinal strain
low testosterone status
low-dose dopamine
low-dose nesiritide
low-frequency/high-frequency
low-volume ed cases
low-volume eds
low-volume physicians
lp-pla
lung weight
lv end systolic volume index
lv structure
lv systolic dysfunction
lvad ai
lvad insertion
lvad surgery
lying
m
m-induced decreases
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system
magnetically levitated lvas
magnetically levitated rotor
main outcome
main outcome measure
maintenance
maintenance of sinus rhythm
maladaptive cardiac remodelling
maladaptive molecular
maladaptive remodelling
male sex
malfunctioning heartmate
malignancies
malondialdehyde bound
management
manipulation of cardiac gene control
mass
md
md95%
mdp
mean ejection fraction
mechanical
mechanical dyssynchrony
mechanical support devices
mechanically assisted circulatory support
median
median age
median baseline st2 level
medicaid services
medical hospitalization
medical management
medical outcomes
medical records
medical resource
medical support
medical therapies
medical treatment guidelines
medically managed diseases
medicare beneficiaries
medicare coverage
medicare fee-for-service
medicare fee-for-service beneficiaries
medicare hospital claims
medicare inpatient
mediterranean
membrane oxygenation
men
mesenchymal transition markers
metabolic changes
metabolic enzymes
metabolic risk factors
metoprolol treatment
metric choice
mg myocardial washout
mice
micrornas in heart failure
middle-aged recreational athletes
midwestern state
mild mr
minnesota living with heart failure
mir-25 expression
mistargeting
mitochondrial damage
mitochondrial oxidative stress
mitochondrial proteome changes
mitochondrial ultrastructural changes
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral stenosis reversed
ml
ml end-diastolic volume
ml/kg/min
mlh
mlhf
mlocardium
mlva
moderate to severe heart failure
modifiable risk factors
modulate hf-related morbidity
molecular biomarkers
molecular mechanism
morpholino-based knockdown
mortality outcomes
mortality/hospitalization
mouse
mouse heart
mouse heart failure
mouse hearts
mouse hf
mouse rad
mouse tac
mouse ventricular myocytes
mri-based models
mrna levels
msea
mt
multicenter
multicenter automatic defibrillator implantation
multicenter trial paradigm-hf
multihospital study
multimarker-based strategy
multiparametric echocardiographic score
multivariable cox modeling
multivariate
multivariate cox regression
murine equivalent
murine myocardium to heart failure
murine resistin
muscle abnormalities
muscle strength
muscle strip stiffness
muscle-wasting syndrome
muscular strength
mutant mice overexpressing hand2
mwt
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2
myocardial phosphodiesterase-2
myocardial t1 changes
myocardial titin hypophosphorylation
myocardium displays
myocyte diameter
myofiber
myofiber shortening velocity
myofibrillar ca(2+)-stimulated atpase activity
myosin binding protein-c phosphorylation
n
n-
na+ channel mrna splice
nad
nafat
national cardiovascular disease registry practice innovation
natriuretic peptide system
nct
negative coronary angiography
negative cross talk
neprilysin blocks renin-angiotensin-aldosteron
neprilysin inhibitor prodrug
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new york heart association class iii heart failure
new-onset
nfat signalling
nicorandil ameliorates mitochondrial dysfunction
nights spent in hospital
non-aas
non-diabetic patients
non-dnx
non-fatal stroke
non-frail participants
noncardiologist physicians
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nonfunctional channels
nonglycosylated
nonpace
nonpace dnx
nonselective
nonsurvivors
nontrastuzumab
nordic walking
norepinephrine-induced hypertrophic responses
normal geometry
np assessment
np levels
np measurement
nt-probnp assay
nt-probnp testing
nurse assessment of cognitive impairment
nursing management
nursing terminologies
nursing-sensitive outcome
nursing-sensitive outcome change scores
nutrition in heart failure
nutritional abnormalities
nuts
o2 consumption rate
obese men
obese participants
obese zsf1
obese zsf1 groups
off-pump sternal sparing approach
office hours
office-based
oht bridged to transplant
open chest model
open stent
open-label crossover study
optimal diuretic therapy
oral glucocorticoid
organisation of care taxonomy
overweight
oxidative stress markers
oxygen
oxygen consumption
oxygen flow
oxygen uptake
pace
pace non-dnx
paco2 cerebral blood flow
paediatric heart failure
paf biosynthetic enzymes
parasympa
passage
passive/stiffness
pathobiology/pathophysiology
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathophysiological origin
pathway alterations
patient compliance
patient management interventions in heart failure cost-effectiveness model
patient preferences
patient safety
patient safety initiatives
patient satisfaction
patient-level regression
patients enrolled in heart failure
patients hospitalized
patients in heart failure
pb cycle
pde superfamily
pde2 activity
pde2 expression
pde2 overexpression
pde2-mediated effects
pediatrc heart failure
pediatric mechanical cardiac
pediatrics
percutaneous coronary revascularization
performance
perk activation destabilized scn5a
perk inhibition
permanent periodic breathing
perturbed mitochondrial function
pf cohort
pf-ah
pf-cpt
pharmacologic management
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine-induced genes
phosphomimic ser77
phosphorylation sites
physical exhaustion
physician adherence
physician continuity
physician follow-up after discharge
physician volume
physicians busy
physio ring
physiologic processes
physiological proteolysis
physique
physique activity
pigs
pilot trial of heart failure
pkc-βii-ser
placebo-controlled clinical trial
plasticity
pluripotency marker nanog
poc measurement
point-of-care systems
policy
polytetrafluoroethylene tube
poor myocardial function
population-based rotterdam study
porcine model of right heart failure
positron emission tomography imaging
post-acute care transfer policy
post-myocardial infarction heart
post-myocardial infarction heart failure patients
post-myocardial infarction patients
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative normalization
power
practice
practice-level
practice-level variation
pre-crt lv
pre-pd
precipitating factor
prediction rule
predictor
preoperative albumin
preoperative clinical
preoperative hypoalbuminemia
preoperative serum albumin
prescriptive 4-year survival
preserved
pression gradient
pressure
pressure-overload-induced hypertrophy
pressure-volume conductance catheter system
prevention strategies
principal discharge diagnosis
principal findings
prior stroke score
priorities
proangiogenic effects
production
prognostic benefit
programmed cell death
progressive disease
propensity
propensity score decile
prospective hf registry
prostate
protectionive effects
protective effects
protective peptides
protein levels
protocol-driven poc testing
province of alberta
proximal circumflex artery
proximal lad
proximal left anterior descending
psoriasis patients
pss
psychometric testing
psychosocial factors
public health
public reporting
pulmonary arterial
pulmonary arterial hypertension medication
pulmonary artery snared
pulse-wave velocity
pump
pump exchanges
pump failure
pure epicatechin
pyridostigmine administration
qrs width
quality
quality improvement database
quality-of-life score
qualité
r-r interval oscillations
race
rad q65p
rad q66p
radial artery tonometry variables
radioenzymatic-
radiological signs
raised blood glucose levels
raloxifene-tre
ras-
ras-blocker uptitration
rat
rat metabolic risk
rate-control patients
rate-control treatment
rates
ratios
rats
readmission metric
readmission metrics
readmissions in heart failure
receiver operating characteristic curve
recent findings
reciprocal downregulation
reciprocal regulation
recommended therapies registry
reduction
refill
refractory
regional circumferential strain
regulation
regulation of feeding
regulator of growth
regulatory
regulatory involvement
regulatory subunit
relaxation/viscoelastic
religious beliefs
remodeling in heart failure
renal atherosclerotic lesions
renal chloride channel gene
renin- angiotensin-aldosterone
reperfusion therapy
resistance training
resistin levels
resource use
respiratory gas
response
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
retention trial
reverse remodeling parameters
reversibility
reversible myocardial ischemia
rhythm
rhythm-
right atrial mass removal
right atrium mass
risk
risk of death
risk of heart failure
risk of hospitalization
risk-adjusted all-cause mortality
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
réseau
réseau meta-analysis
résistancein in heart failure
s1pr
s1pr1 cardiac gene therapy
s1pr1 downregulation
safety end point
salt
sandwich alphalisa
sarcopenic range muscle
schfi
scientific literature
scn5a transcript
sd testosterone
sdqt-to-sdrr ratio
seattle heart failure
secretion
selective β-blocker metoprolol
self-care confidence scale
self-care education
self-care maintenance scale
self-care management scale
self-care of heart failure index
self-management counseling
septal correlated
septal defect
septal wall cs
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 mutant riα proteins
ser83 phosphorylation
serum factors
serum resistin
serum sodium levels
severe cad
sex
sex-adjusted risk
sex-specific model
sham
sham levels
sham-innervated
sham-inv
sham-operated
sheet orientation
short-form quality of life
short-term mortality rates
shortness of breath due to lung congestion
shotgun lc-ms
signal transduction cascade
signalling
signalling cascades
skeletal muscle mass
skeletal muscle sarcomere structure
skilled nursing facilities
skinfold thickness
skm biopsies
skm growth
skm mitochondrial structure
slowed conduction
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
snp rs10927887
social mandate
social support
social support score
socioeconomic status
sodium-restricted dash
soluble guanylate cyclase
soluble st2 in ambulatory patients
southeastern minnesota
sphingosine-1-phosphate receptor
spironolactone dose
sprague-dawley rats
srd
srd brachial
sst2/high-dose
sst2/high-dose bb
sst2/low-dose bb
stable coronary artery disease
stable heart failure patients
standard heart failure medicines
standing blood pressure
statistical standards
statitistical significance
stem cell source
stent coated
stenting in ras
stop hypertension
strain rate at systole
stress
stress conditions
stretch rate
stroke prevention trial
structural heart disease
structure
sts hh
study closure
subcellular alterations
subclinical atherosclerosis
suburban hospitals
sudden
sudden cardiac death
sudden cardiac deaths
sudden death
suppression
surface ecgs
surgical indication
surgical method of transverse aortic constriction
surgical revascularization
surgical ring implantation
surgical treatment
surgically induced myocardial infarction
survival
survival study
survival study in heart failure
surviving left ventricle
sustainability
svr index
swedish national inpatient registry
swedish web-system
swine
swine model
sympathetic control
synchrony
systo
systolic heart failure treatment
systolic human heart failure
systolic left v entricular dysfunction
système proteomics
t
tac surgery
tac-
tac-induced proteomic alterations
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
tapse/pasp
target genes
taxonomy
technical advisors
technique
techniques regression analysis
technologies
temporary centrimag rvad
temps
temps to death
temps-dependent analysis
temps-dependent covariates
temps-dependent cox regression analysis
temps-domain
temps-varying seattle heart failure
tension
tertiary referral centre
test-retest
testosterone group
testosterone status
texas cancer registry-medicare
tgf-β inhibition
tgf-β receptor
tgtetmena
tgtetmena mice
tgtttmena mice
thalassaemia
therapeutic alternative
therapeutic functions
therapeutic interruption
therapeutic left-to-right interatrial shunting
therapeutic options
therapeutic strategy
therapeutic targets
therapy refractory cardiogenic shock
thigh muscle
throughput
time domain heart rate variability
timed up
tissue
tissue doppler imaging
tissuefaxs technologie correlated
titin hypophosphor
titin isoforms
titin modification
tm interventions
tobacco
toxicity
training-induced changes
transcatheter aortic valve
transcription
transforming growth factor beta-dependent
transgenic mice
transient receptor potential cation
transition
transitions of care
translational repression
transmissionral blood flow
transmitral e-wave
transmitral flow velocities
transoesophageal echocardiographic guidance
transplant ineligible patients
transplant-ineligible patients
transplantation eligibility status
trastuzumab use
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill
treadmill testing
treating advanced hf
treatment heart failure
trial
trials
trigger hemoglobin threshold
truncated
tta
ttttmena mice
tunel assay
twist
two-vessel disease model
ues
ultrastructural changes
um/va/va-rt
unclear etiology
uncontrolled hypertension
underlying heart disease
undiagnosed heart disease
unfavorable outcome
unfit
unfit men
unilateral
unit costs
university hospital
university of michigan hf clinic
unloading of the heart
unplanned readmission
urban
urban academic medical center
urgent cardiac transplant
urgent readmission
utilization
v
va healthcare systems
va patients
va-rt cohort
vad group
vad groups
vagal
vascular endothelial growth
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
vegfr2
vehicle
ven
venous thrombolic events
vent failure
venting hemodynamics
ventricle end-diastolic pressure
ventricle overload
ventricular action
ventricular assist device implantation
ventricular assist device support
ventricular contractile
ventricular contractile reserve
ventricular diastolic
ventricular diastolic end diameter
ventricular dilatation
ventricular ejection
ventricular ejection fraction
ventricular ejection fractions
ventricular ejection time
ventricular end-diastolic area
ventricular end-diastolic pressure
ventricular filling
ventricular filling pressure
ventricular fractional area change
ventricular hypertrophy
ventricular longitudinal systolic strain
ventricular midpapillary
ventricular pacing
ventricular power index
ventricular pressure overload
ventricular structure
ventricular support
ventricular systolic
ventricular systolic dysfunction
ventricular tachycardia storm
ventricular wall stress
ventricular-pulmonary arterial coupling
ventricularly paced
veterans
virtual cohorts
vitesse
voltage-gated cardiac na+ channel
volume eds
walking distance
wall stiff
weak grip strength
weight
weight loss
western austral
western society
white
whole grain intake
wilcoxon
wild type
wild-type littermates
willebrand factor
womens health initiative
wrf
wt
yorkshire swine
young woman
zebrafish
zf1 rats
zung
économique
économique analysis
économique climate
économique impact
économique models
économique savings
électronique databases
β-ar stimulation
β-blocker dose
β-blocker uptitration
β-blocker uptitrations
β-blockers therapy
